The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer’s Disease
Open accessAbstract
The aggregation of amyloid-β peptide (Aβ) has been linked to the formation of neuritic plaques, which are pathological hallmarks of Alzheimer’s disease (AD). Various natural compounds have been suggested as therapeutics for AD. Among these compounds, resveratrol has aroused great interest due to its neuroprotective characteristics. Here, we provide evidence that grape skin and grape seed extracts increase the inhibition effect on Aβ aggregation. However, after intravenous injection, resveratrol is rapidly metabolized into both glucuronic acid and sulfate conjugations of the phenolic groups in the liver and intestinal epithelial cells (within less than 2 h), which are then eliminated. In the present study, we show that solid lipid nanoparticles (SLNs) functionalized with an antibody, the anti-transferrin receptor monoclonal antibody (OX26 mAb), can work as a possible carrier to transport the extract to target the brain. Experiments on human brain-like endothelial cells show that the cellular uptake of the OX26 SLNs is substantially more efficient than that of normal SLNs and SLNs functionalized with an unspecific antibody. As a consequence, the transcytosis ability of these different SLNs is higher when functionalized with OX-26.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Levine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,264
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2)
Honary, S., & Zahir, F. (2013) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v12i2.20 · Cited by 1,309
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 1)
Honary, S., & Zahir, F. (2013) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v12i2.19 · Cited by 1,138
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zürcher-Neely, H. A., Heinrikson, R. L., & Ball, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53661-9 · Cited by 799
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 749
Transport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715
Groenning, M. (2010) · Journal of Chemical Biology · doi:10.1007/s12154-009-0027-5 · Cited by 643
Potential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615
Nanoparticles for Brain Drug Delivery
Masserini, M. (2013) · ISRN Biochemistry · doi:10.1155/2013/238428 · Cited by 489
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
In vitro model for evaluating drug transport across the blood–brain barrier
Cecchelli, R., Dehouck, B., Descamps, L., Fenart, L., Buée-Scherrer, V, Duhem, C., Lundquist, S., Rentfel, M., Torpier, G., & Dehouck, M. P. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00083-0 · Cited by 383
Self-citationReis, S., Neves, Lúcio, Martins, & Lima (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s37840 · Cited by 368
A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells
Cecchelli, R., Aday, S., Sevin, E., Almeida, C., Culot, M., Dehouck, L., Coisne, C., Engelhardt, B., Dehouck, M.-P., & Ferreira, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099733 · Cited by 349
Self-citationResveratrol—A boon for treating Alzheimer's disease?
Anekonda, T. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.004 · Cited by 339
Gokce, E., Korkmaz, Dellera, Sandri, Bonferoni, & Ozer, O. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29710 · Cited by 323
Pardridge, W. M., Kang, Y.-S., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 315
R. Neves, A., Lucio, M., L.C. Lima, J., & Reis, S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799945085 · Cited by 313
In vitro models of the blood-brain barrier
Wilhelm, I., Fazakas, C., & Krizbai, I. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1828 · Cited by 298
Citron, M., Diehl, T. S., Gordon, G., Biere, A. L., Seubert, P., & Selkoe, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13170 · Cited by 288
Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier
Schroeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275
Amyloid β-Protein Monomer Folding: Free-Energy Surfaces Reveal Alloform-Specific Differences
Yang, M., & Teplow, D. B. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.039 · Cited by 247
Neves, A. R., Queiroz, J. F., & Reis, S. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0177-x · Cited by 240
Self-citationIn Vitro Models of the Blood-Brain Barrier
Neuhaus, W. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_370 · Cited by 236
Peptide Aggregation in Neurodegenerative Disease
Murphy, R. M. (2002) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.4.092801.094202 · Cited by 228
Conformational Differences between Two Amyloid β Oligomers of Similar Size and Dissimilar Toxicity
Ladiwala, A. R. A., Litt, J., Kane, R. S., Aucoin, D. S., Smith, S. O., Ranjan, S., Davis, J., Van Nostrand, W. E., & Tessier, P. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.329763 · Cited by 225
Resveratrol in prevention and treatment of common clinical conditions of aging.
Markus, M. A., & Morris, B. J. (2008) · PubMed Central · Cited by 196
Loureiro, J. A., Gomes, B., Fricker, G., Coelho, M. A. N., Rocha, S., & Pereira, M. C. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.04.041 · Cited by 179
Self-citationBiogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptides
Evin, G., & Weidemann, A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00063-3 · Cited by 170
Pedroso, D. C. S., Tellechea, A., Moura, L. I. F., Fidalgo-Carvalho, I., Duarte, J., Carvalho, E., & Ferreira, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016114 · Cited by 151
Design strategies for anti-amyloid agents
Mason, J. M., Kokkoni, N., Stott, K., & Doig, A. J. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00100-3 · Cited by 127
Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa, E., Pampalakis, G., Niarakis, A., Romero, I. A., Weksler, B., Couraud, P.-O., & Antimisiaris, S. G. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.015 · Cited by 122
Neves, A. R., Queiroz, J. F., Weksler, B., Romero, I. A., Couraud, P.-O., & Reis, S. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/49/495103 · Cited by 122
Self-citationNeves, A. R., Queiroz, J. F., Lima, S. A. C., Figueiredo, F., Fernandes, R., & Reis, S. (2015) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2015.10.057 · Cited by 121
Self-citationPehlivan, S. B. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1156-7 · Cited by 114
The amyloid‐β peptide and its role in Alzheimer's disease
Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 103
Lindberg, D. J., Wranne, M. S., Gatty, M. G., Westerlund, F., & Esbjörner, E. K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.132 · Cited by 101
Targeting Nanoparticles Across The Blood–Brain Barrier with Monoclonal Antibodies
Loureiro, J. A., Gomes, B., Coelho, M. A. N., Pereira, M. D. C., & Rocha, S. (2014) · Nanomedicine · doi:10.2217/nnm.14.27 · Cited by 99
Self-citationNanoscale Delivery of Resveratrol towards Enhancement of Supplements and Nutraceuticals
Neves, A. R., Martins, S., Segundo, M. A., & Reis, S. (2016) · Nutrients · doi:10.3390/nu8030131 · Cited by 97
Self-citationMiniAp‐4: A Venom‐Inspired Peptidomimetic for Brain Delivery
Oller‐Salvia, B., Sánchez‐Navarro, M., Ciudad, S., Guiu, M., Arranz‐Gibert, P., Garcia, C., Gomis, R. R., Cecchelli, R., García, J., Giralt, E., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508445 · Cited by 96
β-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease
Andreasen, N., & Blennow, K. (2002) · Peptides · doi:10.1016/s0196-9781(02)00056-6 · Cited by 86
Dual ligand immunoliposomes for drug delivery to the brain
Loureiro, J. A., Gomes, B., Fricker, G., Cardoso, I., Ribeiro, C. A., Gaiteiro, C., Coelho, M. A. N., Pereira, M. D. C., & Rocha, S. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.06.067 · Cited by 65
Self-citationMartins, S., Tho, I., Souto, E. B., Ferreira, D., & Brandl, M. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.12.015 · Cited by 62
Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
Rosa, G. D., Salzano, G., Caraglia, M., & Abbruzzese, A. (2011) · Current Drug Metabolism · doi:10.2174/138920012798356943 · Cited by 62
Biswas, S., Dodwadkar, N. S., Sawant, R. R., & Torchilin, V. P. (2011) · Bioconjugate Chemistry · doi:10.1021/bc2002133 · Cited by 60
Small molecule inhibitors of Abetaassembly
LeVine, H. (2007) · Amyloid · doi:10.1080/13506120701461020 · Cited by 58
Fluorinated beta-sheet breaker peptides
Loureiro, J. A., Crespo, R., Börner, H. G., Martins, P. M., Rocha, F. A., Coelho, M. A. N., Pereira, M. D. C., & Rocha, S. (2014) · Journal of Materials Chemistry B · doi:10.1039/c3tb21483d · Cited by 58
Self-citationTargeting of skeletal muscle in vitro using biotinylated immunoliposomes
Schnyder, A., Krähenbühl, S., Török, M., Drewe, J., & Huwyler, J. (2004) · Biochemical Journal · doi:10.1042/bj20031034 · Cited by 54
Immunoliposomes Doubly Targeted to Transferrin Receptor and to α-Synuclein
Loureiro, J. A., Gomes, B., Coelho, M. A. N., Pereira, M. D. C., & Rocha, S. (2015) · Future Science OA · doi:10.4155/fso.15.71 · Cited by 33
Self-citationPeptide-surfactant interactions: consequences for the amyloid-beta structure.
Rocha, S., Loureiro, J., Brezesinski, G., & Pereira, M. (2012) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2012.02.129 · Cited by 27
Self-citationCharged surfactants induce a non‐fibrillar aggregation pathway of amyloid‐beta peptide
Loureiro, J. A., Rocha, S., & Pereira, M. D. C. (2013) · Journal of Peptide Science · doi:10.1002/psc.2535 · Cited by 26
Self-citationElectrochemical Detection of Amyloid-Beta Aggregation in the Presence of Resveratrol
Hung, V. W. S., Cheng, X. R., Li, N., Veloso, A. J., & Kerman, K. (2013) · Journal of The Electrochemical Society · doi:10.1149/2.014307jes · Cited by 23
Fluorescence as a Tool to Study Lipid-Protein Interactions: The Case of α-Synuclein
González-Horta, A., Hernández, B. G., & Chávez-Montes, A. (2013) · Open Journal of Biophysics · doi:10.4236/ojbiphy.2013.31a014 · Cited by 12
Cited by
Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms
Dad, H. A., Gu, T.-W., Zhu, A.-Q., Huang, L.-Q., & Peng, L.-H. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.030 · Cited by 745
Alzheimer’s disease and its treatment by different approaches: A review
Srivastava, S., Ahmad, R., & Khare, S. K. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113320 · Cited by 467
Gut microbial molecules in behavioural and neurodegenerative conditions
Needham, B. D., Kaddurah-Daouk, R., & Mazmanian, S. K. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-00381-0 · Cited by 379
McClements, D. J. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.08.004 · Cited by 322
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
Satapathy, M. K., Yen, T.-L., Jan, J.-S., Tang, R.-D., Wang, J.-Y., Taliyan, R., & Yang, C.-H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081183 · Cited by 318
Metadata
- Authors
- Loureiro, J., Andrade, S., Duarte, A., Neves, A., Queiroz, J., Nunes, C., Sevin, E., Fenart, L., Gosselet, F., Coelho, M., & Pereira, M.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-02-13
- Volume
- 22
- Issue
- 2
- Pages
- 277
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2587902106
- Cited by
- 341
- References
- 56
- FWCI
- 17.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.